Agency Information Collection Activities: Proposed Collection; Comments Requested: Prescription Drug Monitoring Program Questionnaire, 1709 [E9-467]
Download as PDF
Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: None. Bureau
of Alcohol, Tobacco, Firearms and
Explosives.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Business or other forprofit. Other: None. Abstract: The
information is necessary to ensure that
explosive materials can be effectively
traced. All licensed importers are
required to identify by marking all
explosive materials they import for sale
or distribution. The process provides
valuable information in explosion and
bombing investigations.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: There will be an estimated 15
respondents, who will spend 1 hour
placing marks of identification on
imported explosives.
(6) An estimate of the total burden (in
hours) associated with the collection:
There are an estimated 45 total burden
hours associated with this collection.
If additional information is required
contact: Lynn Bryant, Clearance Officer,
United States Department of Justice,
Planning and Policy Staff, Justice
Management Division, Suite 1600,
Patrick Henry Building, 601 D Street,
NW., Washington, DC 20530.
Dated: January 8, 2009.
Lynn Bryant,
Department Clearance Officer, PRA, United
States Department of Justice.
[FR Doc. E9–472 Filed 1–12–09; 8:45 am]
BILLING CODE 4410–FY–P
VerDate Nov<24>2008
19:10 Jan 12, 2009
Jkt 217001
e.g., permitting electronic submission of
responses.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0037]
Agency Information Collection
Activities: Proposed Collection;
Comments Requested: Prescription
Drug Monitoring Program
Questionnaire
ACTION: 60-Day Notice of Information
Collection Under Review.
(2) Title of the Form/Collection:
Identification of Imported Explosives
Materials.
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA), will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. Comments
are encouraged and will be accepted
until March 16, 2009. This process is
conducted in accordance with 5 CFR
1320.10.
If you have comments, especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact Mark W. Caverly, Chief,
Liaison and Policy Section, Office of
Diversion Control, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152, Telephone (202)
307–7297.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
1709
Overview of Information Collection
1117–0037
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Prescription Drug Monitoring Program
Questionnaire.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: None. Office
of Diversion Control, Drug Enforcement
Administration, Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: States.
Other: None.
Abstract: This questionnaire permits
the Drug Enforcement Administration to
compile and evaluate information
regarding the design, implementation
and operation of State prescription
monitoring programs. Such information
allows DEA to assist states in the
development of new programs designed
to enhance the ability of both DEA and
State authorities to prevent, detect, and
investigate the diversion and abuse of
controlled substances.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 51 persons
complete the Prescription Monitoring
Program Questionnaire electronically, at
5 hours per form, for an annual burden
of 255 hours.
(6) An estimate of the total public
burden (in hours) associated with the
collection: It is estimated that there are
255 burden hours associated with this
collection.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: January 8, 2009.
Lynn Bryant,
Department Clearance Officer, PRA, United
States Department of Justice.
[FR Doc. E9–467 Filed 1–12–09; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\13JAN1.SGM
13JAN1
Agencies
[Federal Register Volume 74, Number 8 (Tuesday, January 13, 2009)]
[Notices]
[Page 1709]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-467]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0037]
Agency Information Collection Activities: Proposed Collection;
Comments Requested: Prescription Drug Monitoring Program Questionnaire
ACTION: 60-Day Notice of Information Collection Under Review.
-----------------------------------------------------------------------
The Department of Justice (DOJ), Drug Enforcement Administration
(DEA), will be submitting the following information collection request
to the Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. The proposed
information collection is published to obtain comments from the public
and affected agencies. Comments are encouraged and will be accepted
until March 16, 2009. This process is conducted in accordance with 5
CFR 1320.10.
If you have comments, especially on the estimated public burden or
associated response time, suggestions, or need a copy of the proposed
information collection instrument with instructions or additional
information, please contact Mark W. Caverly, Chief, Liaison and Policy
Section, Office of Diversion Control, Drug Enforcement Administration,
8701 Morrissette Drive, Springfield, VA 22152, Telephone (202) 307-
7297.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
Evaluate the accuracy of the agencies estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used;
Enhance the quality, utility, and clarity of the
information to be collected; and
Minimize the burden of the collection of information on
those who are to respond, including through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses.
Overview of Information Collection 1117-0037
(1) Type of Information Collection: Extension of a currently
approved collection.
(2) Title of the Form/Collection: Prescription Drug Monitoring
Program Questionnaire.
(3) Agency form number, if any, and the applicable component of the
Department of Justice sponsoring the collection: Form Number: None.
Office of Diversion Control, Drug Enforcement Administration,
Department of Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract:
Primary: States.
Other: None.
Abstract: This questionnaire permits the Drug Enforcement
Administration to compile and evaluate information regarding the
design, implementation and operation of State prescription monitoring
programs. Such information allows DEA to assist states in the
development of new programs designed to enhance the ability of both DEA
and State authorities to prevent, detect, and investigate the diversion
and abuse of controlled substances.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond: It is estimated
that 51 persons complete the Prescription Monitoring Program
Questionnaire electronically, at 5 hours per form, for an annual burden
of 255 hours.
(6) An estimate of the total public burden (in hours) associated
with the collection: It is estimated that there are 255 burden hours
associated with this collection.
If additional information is required contact: Lynn Bryant,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Patrick Henry
Building, Suite 1600, 601 D Street, NW., Washington, DC 20530.
Dated: January 8, 2009.
Lynn Bryant,
Department Clearance Officer, PRA, United States Department of Justice.
[FR Doc. E9-467 Filed 1-12-09; 8:45 am]
BILLING CODE 4410-09-P